Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2026
DR. STEENKISTE EDWIN from Brugge, company number BE0806061486, closed financial year 2026 with a result of € 223,617 after tax. For that financial year DR. STEENKISTE EDWIN recorded a gross margin of € 333,627 and equity of € 862,884. Compared with financial year 2025, the result moved from € 225,013 to € 223,617. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 20, 2026.
€ 862,884
▼ 30% vs 2025
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 223,617
▼ 1% vs 2025
Profit after tax over the fiscal year.
€ 363,838
▼ 43% vs 2025
Cash and bank balances on the last day of the fiscal year.
€ 592,867 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2026
€ 39,358
▼ 28% vs 2025
Book value of vehicles, furniture and equipment.
Debts at end 2026
None
No bank loans on the last day of the fiscal year.
€ 191
▼ 63% vs 2025
Supplier invoices still open on the last day of the fiscal year.
€ 29,627
Taxes, VAT and social contributions still to pay.
| 2023 | 2024 | 2025 | 2026 | Change 2025 → 2026 | |
|---|---|---|---|---|---|
| Gross margin | € 236,988 | € 342,928 | € 327,469 | € 333,627 | ▲ 2% |
| Profit after taxes | € 161,460 | € 240,200 | € 225,013 | € 223,617 | ▼ 1% |
| Equity | € 960,332 | € 1,200,532 | € 1,232,135 | € 862,884 | ▼ 30% |
| Total debts | € 67,451 | € 47,838 | € 167,672 | € 177,549 | ▲ 6% |
| Cash | € 499,622 | € 869,034 | € 639,609 | € 363,838 | ▼ 43% |
| Retained profit | € 947,932 | € 1,188,132 | € 1,219,735 | € 850,484 | ▼ 30% |
| Dividend | € 0 | € 0 | € 193,410 | € 592,867 | ▲ 207% |
| Balance sheet total | € 1,027,782 | € 1,248,370 | € 1,399,806 | € 1,040,432 | ▼ 26% |
Key figures of DR. STEENKISTE EDWIN, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 30 January 2028.
What happened to DR. STEENKISTE EDWIN?
What happened at DR. STEENKISTE EDWIN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2026: profit of € 223,617 (▼ 1% vs 2025). Source: NBB ↗
- Edwin Steenkiste became a director. NBB
- New establishment in Roeselare. KBO
- Start of the company according to the CBE. KBO
In short
From € 161,460 profit in 2023 to € 223,617 profit in 2026.
Paid € 371,056 in corporate taxes since 2023.
Best year ever: 2024, with € 240,200 profit.
Paid out € 786,278 in dividends to the owners in total.
Management
Behind DR. STEENKISTE EDWIN is Edwin Steenkiste. It owns 16.7% of Pathologie itself.
Directors
According to the 2026 annual accounts
since 2021
Establishments
Establishment units
Physical locations of this company
Sint-Andriesdreef 7
8200 Brugge
Deltalaan 1
8800 Roeselare
Active since 1 September 2008
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0806.061.486
- VAT number
- BE 0806.061.486
- Registered office
- Sint-Andriesdreef 7, 8200 Brugge
- Names & denominations
- DR. STEENKISTE EDWIN
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 1 September 2008
- Peppol
- Not registered